Clinical efficacy of the selective endothelin A receptor antagonist, atrasentan, in patients with diabetes and chronic kidney disease (CKD)

Autor: Andress, Dennis L., Coll, Blai, Pritchett, Yili, Brennan, John, Molitch, Mark, Kohan, Donald E.
Zdroj: In Life Sciences 15 October 2012 91(13-14):739-742
Databáze: ScienceDirect